Pharmaceutical analysis is traditionally defined as analytical chemistry dealing with drugs both as bulk drug substances and as pharmaceutical products (formulations). However, in academia, as well as in the pharmaceutical industry, other branches of analytical chemistry are also involved, viz. bioanalytical chemistry, drug metabolism studies and analytical biotechnology. The development of drugs in the pharmaceutical industry is a long-term process, often taking more than a decade from the start of a research project to the appearance of a drug on the market.

That process involves several decision points, such as the choice of the candidate drug after the preclinical screening phase, the investigational new drug (IND) application before testing the compound for the first time in man, and finally the new drug application (NDA) which summarizes the data obtained from all the studies needed for marketing approval of the drug as a medicine.

Authors can share their research in our journal through online portal by using this link: https://www.longdom.org/editorial-tracking/publisher.php and through email.

With Regards,

Anna D Parker

Editorial Assistant

Journal of pharmaceutica Analytica Acta

Email: pharmaanalytica@engjournals.com